
Verrica Pharmaceuticals Inc.: shareholders and insiders
Price
$2.85
November 18, 2026Market cap $49M
What Ploutos Investor adds for Verrica Pharmaceuticals
Part of Ploutos Investor, €9.99 a month
- The full history: 5 fiscal years, from 2021
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Aug 18, 2026, from their own Form 4 filings.
Bought on the market
$18M
5 people
Sold on the market
–
nobody
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $210.9K by 4 people·no sales
- 2025: bought $18M by 5 people, no sales
- 2026: bought $210.9K by 4 people, no sales
- Aug 18, 2026Noah L. RosenbergCMOKind
- Aug 18, 2026John J. KirbyInterim CFOKind
- Aug 17, 2026David ZawitzChief Operating OfficerKind
- Aug 17, 2026Jayson RiegerCEO and PresidentKind
- Aug 17, 2026Noah L. RosenbergCMOKind
- Aug 14, 2026Jayson RiegerCEO and PresidentKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Noah L. RosenbergCMO | 2,030 | $4.92 | $10.0K | Form 4 | |
| Aug 18, 2026 | John J. KirbyInterim CFO | 5,000 | $4.93 | $24.7K | Form 4 | |
| Aug 17, 2026 | David ZawitzChief Operating Officer | 6,000 | $4.98 | $29.9K | Form 4 | |
| Aug 17, 2026 | Jayson RiegerCEO and President | 5,000 | $4.91 | $24.6K | Form 4 | |
| Aug 17, 2026 | Noah L. RosenbergCMO | 4,200 | $4.91 | $20.6K | Form 4 | |
| Aug 14, 2026 | Jayson RiegerCEO and President | 20.0K | $5.06 | $101.2K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 9, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by VRCA's officers and directors from 2018 up to November 18, 2025, 8 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 3 more, back to 2018
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Paul B Manningwith 2 more personsShare of class49.9%
- Caligan Partners LPwith 1 more personShare of class9.99%
- Affinity Asset Advisors, LLCwith 1 more personShare of class5.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Paul B Manningwith 2 more persons | 49.9% | 8.06M | Nov 28, 2025 | 13D/A | |
| Caligan Partners LPwith 1 more person | 9.99% | 6.50M | Dec 30, 20253 filings since Feb 12, 2025 | 13D/A | |
| Affinity Asset Advisors, LLCwith 1 more person | 5.50% | 884.2K | Jan 29, 20262 filings since Dec 3, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Caligan Partners LP10.0%From the filing of Dec 30, 2025
On December 26, 2025, pursuant to the Purchase Agreement, the Issuer appointed Dr. Charles Frantzreb, a designee selected by Caligan, as a Class I member of the Board, effective immediately.
From the filing of Dec 30, 2025
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter
- Renaissance TechnologiesIn the quarter+46%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 39.0K | $200.0K | 0.00% | |
| Renaissance Technologies | 31.9K | +46% | $200.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 1.12% of its shares outstanding were held short, -1.8% since the report before.
- Shares held short
- 192.6K
- 1.12%
- Since the report before196.2K on Sep 30, 2026
- -1.8%
- 3.8
- 50.1K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 46%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 4.21M
- Nov 15, 2023: Shares held short 4.26M
- Nov 30, 2023: Shares held short 3.99M
- Dec 15, 2023: Shares held short 3.65M
- Dec 29, 2023: Shares held short 5.27M
- Jan 12, 2024: Shares held short 5.55M
- Jan 31, 2024: Shares held short 4.43M
- Feb 15, 2024: Shares held short 4.38M
- Feb 29, 2024: Shares held short 4.43M
- Mar 15, 2024: Shares held short 4.40M
- Mar 28, 2024: Shares held short 4.18M
- Apr 15, 2024: Shares held short 3.84M
- Apr 30, 2024: Shares held short 3.62M
- May 15, 2024: Shares held short 3.84M
- May 31, 2024: Shares held short 3.54M
- Jun 14, 2024: Shares held short 3.57M
- Jun 28, 2024: Shares held short 3.91M
- Jul 15, 2024: Shares held short 3.96M
- Jul 31, 2024: Shares held short 3.69M
- Aug 15, 2024: Shares held short 4.19M
- Aug 30, 2024: Shares held short 2.98M
- Sep 13, 2024: Shares held short 3.25M
- Sep 30, 2024: Shares held short 3.63M
- Oct 15, 2024: Shares held short 4.53M
- Oct 31, 2024: Shares held short 4.37M
- Nov 15, 2024: Shares held short 4.51M
- Nov 29, 2024: Shares held short 3.04M
- Dec 13, 2024: Shares held short 2.00M
- Dec 31, 2024: Shares held short 1.95M
- Jan 15, 2025: Shares held short 1.82M
- Jan 31, 2025: Shares held short 2.02M
- Feb 14, 2025: Shares held short 1.99M
- Feb 28, 2025: Shares held short 2.03M
- Mar 14, 2025: Shares held short 2.22M
- Mar 31, 2025: Shares held short 2.85M
- Apr 15, 2025: Shares held short 2.84M
- Apr 30, 2025: Shares held short 2.71M
- May 15, 2025: Shares held short 3.15M
- May 30, 2025: Shares held short 2.27M
- Jun 13, 2025: Shares held short 2.97M
- Jun 30, 2025: Shares held short 1.72M
- Jul 15, 2025: Shares held short 2.21M
- Jul 31, 2025: Shares held short 149.8K
- Aug 15, 2025: Shares held short 146.7K
- Aug 29, 2025: Shares held short 165.5K
- Sep 15, 2025: Shares held short 169.9K
- Sep 30, 2025: Shares held short 428.4K
- Oct 15, 2025: Shares held short 302.2K
- Oct 31, 2025: Shares held short 419.7K
- Nov 14, 2025: Shares held short 446.7K
- Nov 28, 2025: Shares held short 515.6K
- Dec 15, 2025: Shares held short 380.6K
- Dec 31, 2025: Shares held short 292.3K
- Jan 15, 2026: Shares held short 299.0K
- Jan 30, 2026: Shares held short 338.1K
- Feb 13, 2026: Shares held short 384.6K
- Feb 27, 2026: Shares held short 405.0K
- Mar 13, 2026: Shares held short 478.6K
- Mar 31, 2026: Shares held short 497.8K
- Apr 15, 2026: Shares held short 581.3K
- Apr 30, 2026: Shares held short 582.2K
- May 15, 2026: Shares held short 412.5K
- May 29, 2026: Shares held short 379.3K
- Jun 15, 2026: Shares held short 351.8K
- Jun 30, 2026: Shares held short 324.7K
- Jul 15, 2026: Shares held short 315.8K
- Jul 31, 2026: Shares held short 287.7K
- Aug 14, 2026: Shares held short 269.3K
- Aug 31, 2026: Shares held short 222.6K
- Sep 15, 2026: Shares held short 202.8K
- Sep 30, 2026: Shares held short 196.2K
- Oct 15, 2026: Shares held short 192.6K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading45.1% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 45.1% of the shares in the reported trades were short sales, against 33.5% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 45.1%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 33.5%
- Change
- +11.6 pts
- Short sales a dayon average, of 28.6K shares
- 12.9K
- More than atof 3,656 US-listed companies, same days
- 33%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 39%
- Oct 13, 2026: Short sales 24.7%
- Oct 14, 2026: Short sales 70.7%
- Oct 15, 2026: Short sales 29.4%
- Oct 16, 2026: Short sales 16.5%
- Oct 19, 2026: Short sales 30%
- Oct 20, 2026: Short sales 20.3%
- Oct 21, 2026: Short sales 44.9%
- Oct 22, 2026: Short sales 33.2%
- Oct 23, 2026: Short sales 24.6%
- Oct 26, 2026: Short sales 31%
- Oct 27, 2026: Short sales 75.2%
- Oct 28, 2026: Short sales 56.4%
- Oct 29, 2026: Short sales 17.2%
- Oct 30, 2026: Short sales 57.6%
- Nov 2, 2026: Short sales 44.7%
- Nov 3, 2026: Short sales 76.5%
- Nov 4, 2026: Short sales 28.3%
- Nov 5, 2026: Short sales 64.4%
- Nov 6, 2026: Short sales 28.7%
- Nov 9, 2026: Short sales 27.3%
- Nov 10, 2026: Short sales 80.6%
- Nov 11, 2026: Short sales 73.9%
- Nov 12, 2026: Short sales 26.3%
- Nov 13, 2026: Short sales 48%
- Nov 16, 2026: Short sales 23.3%
- Nov 17, 2026: Short sales 39%
- Nov 18, 2026: Short sales 56.3%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Paul B ManningDirector,TenPercentOwnerDirectly3.96M
- Joseph EdelmanTenPercentOwnerDirectly–
- Perceptive Advisors LlcTenPercentOwnerDirectly–
- John A Stalfort IIIDirectorDirectly1.82M
- Ted WhitePRESIDENT AND CEODirectly216.0K
- Jayson RiegerCEO and PresidentDirectly207.6K
- Christopher G. HayesCHIEF LEGAL OFFICERDirectly176.5K
- Gary GoldenbergChief Medical OfficerDirectly94.3K
- Joe BonaccorsoCHIEF COMMERCIAL OFFICERDirectly73.1K
- Terry KohlerCHIEF FINANCIAL OFFICERDirectly44.7K
- David ZawitzChief Operating OfficerDirectly27.0K
- John J. KirbyInterim CFODirectly24.0K
- Noah L. RosenbergCMODirectly8,587
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Paul B ManningDirector,TenPercentOwner | 3.96M | 3.35M | Nov 25, 2025 | Form 4 |
| Joseph EdelmanTenPercentOwner | – | 7.10M | Dec 29, 2023 | Form 4 |
| Perceptive Advisors LlcTenPercentOwner | – | 6.78M | Dec 26, 2023 | Form 4 |
| John A Stalfort IIIDirector | 1.82M | – | Nov 22, 2024 | Form 4 |
| Ted WhitePRESIDENT AND CEO | 216.0K | – | Aug 27, 2024 | Form 4 |
| Jayson RiegerCEO and President | 207.6K | – | Aug 17, 2026 | Form 4 |
| Christopher G. HayesCHIEF LEGAL OFFICER | 176.5K | – | Mar 17, 2025 | Form 4 |
| Gary GoldenbergChief Medical Officer | 94.3K | – | Aug 27, 2024 | Form 4 |
| Joe BonaccorsoCHIEF COMMERCIAL OFFICER | 73.1K | – | Aug 27, 2024 | Form 4 |
| Terry KohlerCHIEF FINANCIAL OFFICER | 44.7K | – | Aug 27, 2024 | Form 4 |
| David ZawitzChief Operating Officer | 27.0K | – | Aug 17, 2026 | Form 4 |
| John J. KirbyInterim CFO | 24.0K | – | Aug 18, 2026 | Form 4 |
| Noah L. RosenbergCMO | 8,587 | – | Aug 18, 2026 | Form 4 |
A lower bound: it counts only the 13 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
| ETF | Weight in the fund | Holdings as of |
|---|---|---|
| IWCiShares Micro-Cap ETF | 0.01% | Jun 30, 2026 |
| VXFVanguard Extended Market Index Fund | 0.00% | Jun 30, 2026 |
| DFASDimensional U.S. Small Cap ETF | 0.00% | Jul 31, 2026 |
3 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 35
- Q4 2025: Managers 50
- Q1 2026: Managers 40
- Q2 2026: Managers 43
Institutional investors by quarter
The fund managers holding VRCA, quarter by quarter, from Q2 2018 to Q2 2025, 29 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 43 managers held 4.66M shares, worth $29M. During the quarter 9 opened a position, 6 closed one, 6 added and 11 trimmed.
The largest holders, Q2 2026
- Caligan PartnersIn the quarter
- Cannell CapitalIn the quarter+14%
- Affinity Asset AdvisorsIn the quarter
- Velan Capital Investment ManagementIn the quarter
- Armistice CapitalIn the quarter-18%
- Boothbay Fund ManagementIn the quarter
- Vanguard Capital ManagementIn the quarter+48%
- MarinerIn the quarter+744%
- Geode Capital ManagementIn the quarter-0.5%
- BlackRockIn the quarter+93%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Caligan Partners | 923.9K | $5.7M | |
| Cannell Capital | 783.9K | +14% | $4.8M |
| Affinity Asset Advisors | 707.3K | $4.3M | |
| Velan Capital Investment Management | 471.6K | $2.9M | |
| Armistice Capital | 426.3K | -18% | $2.6M |
| Boothbay Fund Management | 280.7K | $1.7M | |
| Vanguard Capital Management | 279.3K | +48% | $1.7M |
| Mariner | 207.2K | +744% | $1.3M |
| Geode Capital Management | 138.2K | -0.5% | $845.7K |
| BlackRock | 74.3K | +93% | $455.0K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Verrica Pharmaceuticals's filings show?
Who buys and sells is one part of Verrica Pharmaceuticals's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have VRCA's insiders bought or sold?
From Jun 9, 2026 to Aug 18, 2026 Verrica Pharmaceuticals's insiders bought $210.9K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.
Which well-known managers hold VRCA?
2 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $200.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.